Overview

Corporate Profile

Laboratory Corporation of America® Holdings, an S&P 500 company, is the world’s leading healthcare diagnostics company, providing comprehensive clinical laboratory services through LabCorp Diagnostics, and end-to-end drug development support through Covance Drug Development. LabCorp is a pioneer in commercializing new diagnostic technologies and is improving people’s health by delivering the combination of world-class diagnostics, drug development and knowledge services. With combined revenue pro... More >>

Recent NewsMore >>
DateTitle 
05/18/15LabCorp Announces Full Portfolio of Hepatitis C Virus Drug Resistance Assays
Expanded testing services enable precision medicine by providing clinicians with information to select optimal treatment and characterize treatment failure BURLINGTON, N.C.--(BUSINESS WIRE)--May 18, 2015-- Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) today announced the launch of two new Hepatitis C Virus (HCV) drug resistance assays. The HCV NS5A and NS5B Drug Resistance Assays expand LabCorp’s portfolio of HCV resistance... 
Printer Friendly Version
05/12/15LabCorp is Scheduled to Present at the UBS Global Healthcare Conference
BURLINGTON, N.C.--(BUSINESS WIRE)--May 12, 2015-- Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) today announced it will participate at the UBS Global Healthcare Conference. LabCorp’s presentation is planned for Tuesday, May 19, 2015 at 8:00 AM (ET). A live audio webcast of the presentation will be available via the Company website at www.labcorp.com and archived for replay. About LabCorp® L... 
Printer Friendly Version
05/06/15LabCorp is Scheduled to Present at the Bank of America Merrill Lynch 2015 Health Care Conference
BURLINGTON, N.C.--(BUSINESS WIRE)--May 6, 2015-- Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) today announced it will participate at the Bank of America Merrill Lynch 2015 Health Care Conference. LabCorp’s presentation is planned for Thursday, May 14, 2015 at 11:40 AM (ET). A live audio webcast of the presentation will be available via the Company website at www.labcorp.com and archived for replay. About... 
Printer Friendly Version
04/27/15Laboratory Corporation of America® Holdings Announces 2015 First Quarter Results and Raises 2015 Adjusted EPS Guidance
Q1 Net revenue of $1.8 billion, up 24% over last year Q1 Diluted EPS of $0.01; Q1 Adjusted EPS of $1.73, up 15% over last year 2015 Adjusted EPS guidance raised to $7.55 - $7.90, compared to $6.80 in 2014 BURLINGTON, N.C.--(BUSINESS WIRE)--Apr. 27, 2015-- Laboratory Corporation of America® Holdings (LabCorp® or the “Company”) (NYSE: LH) today announced results for the quarter ended March 3... 
Printer Friendly Version
Upcoming EventsMore >>
There are currently no events scheduled.
LH (Common)
ExchangeNYSE
Price$117.95
Change Stock is Down 0.96
Intraday High$119.48
Intraday Low$117.69
Volume1,239,776
Data as of 05/29/15
4:06 p.m. ET
Minimum 20 minute delay
Refresh quote

Reports & Performance

2014 Annual Report

2013 Annual Report

2012 Annual Report

2011 Annual Report

2010 Annual Report

2009 Annual Report

2008 Annual Report

2007 Annual Report

2006 Annual Report

Latest Earnings Release